Drug Shortage Report for TARO-BUPROPION XL

Last updated on 2025-02-10 History
Report ID 202125
Drug Identification Number 02475804
Brand name TARO-BUPROPION XL
Common or Proper name BUPROPION
Company Name SUN PHARMA CANADA INC
Market Status MARKETED
Active Ingredient(s) BUPROPION HYDROCHLORIDE
Strength(s) 150MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 500
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-08-10
Estimated end date 2025-03-28
Actual end date
Shortage status Actual shortage
Updated date 2025-02-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2025-02-10 French Compare
v23 2025-02-10 English Compare
v22 2025-01-28 French Compare
v21 2025-01-28 English Compare
v20 2025-01-15 French Compare
v19 2025-01-15 English Compare
v18 2024-11-11 French Compare
v17 2024-11-11 English Compare
v16 2024-10-16 French Compare
v15 2024-10-16 English Compare
v14 2024-09-09 French Compare
v13 2024-09-09 English Compare
v12 2024-06-14 French Compare
v11 2024-06-14 English Compare
v10 2024-05-09 French Compare
v9 2024-05-09 English Compare
v8 2024-01-05 French Compare
v7 2024-01-05 English Compare
v6 2023-11-02 French Compare
v5 2023-11-02 English Compare

Showing 1 to 20 of 24